Three gene sets could predict response to rheumatoid arthritis therapies

Three gene expression signatures can help rheumatologists predict which patients are more likely to respond to tumor necrosis factor inhibitors (TNFi) or B-cell depletion therapies in patients with moderate to severe rheumatoid arthritis.

Leave a Reply

Your email address will not be published. Required fields are marked *